Related Experiment Video

Updated: Jun 10, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor

James J Manfredi1

  • 1Department of Oncological Sciences, Mount Sinai School of Medicine, New York, New York 10029, USA. james.manfredi@mssm.edu

Genes & Development
|August 4, 2010
PubMed

Insights

The mouse double minute 2 homolog (Mdm2) protein, a known regulator of tumor suppressor p53, also plays crucial roles in cancer independently of p53. Mdm2 is a potential therapeutic target due to its complex functions in human cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The mouse double minute 2 homolog (Mdm2) is a well-established negative regulator of the tumor suppressor protein p53.
  • Emerging research indicates Mdm2 activation in oncogenic pathways, independent of p53.
  • This suggests multifaceted roles for Mdm2 in cancer beyond p53 suppression.

Purpose of the Study:

  • To explore the p53-independent functions of Mdm2 in cancer.
  • To investigate the potential tumor suppressor roles of Mdm2 in specific contexts.
  • To highlight Mdm2 as a significant player and therapeutic target in human cancer.

Main Methods:

  • Literature review of recent studies on Mdm2.
  • Analysis of Mdm2's interaction with p53 and other oncogenic pathways.
  • Evaluation of Mdm2's dual role as an oncogene and potential tumor suppressor.

Main Results:

  • Mdm2 exhibits p53-independent activation in various oncogenic pathways.
  • Evidence suggests Mdm2 can function as a tumor suppressor in certain cellular contexts.
  • Mdm2's complex roles underscore its significance in cancer development.

Conclusions:

  • Mdm2 is a critical factor in human cancer, acting through both p53-dependent and p53-independent mechanisms.
  • The dual role of Mdm2 necessitates a nuanced understanding for therapeutic strategies.
  • Mdm2 represents a promising therapeutic target for various human cancers.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...